COVID-19-positive cancer patients undergoing active anticancer treatment: An analysis of clinical features and outcomes
Background: Cancer patients, particularly those on active anticancer treatment, are reportedly at a high risk of severe coronavirus disease 2019 (COVID-19) infection and death. This study aimed to describe the clinical characteristics and outcomes of patients diagnosed with COVID-19 whilst on antica...
Guardado en:
Autores principales: | Jamshed Ali, Kashif Sajjad, Amer Rehman Farooqi, Muhammad Tahir Aziz, Ayesha Rahat, Sarah Khan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/351d28f0495e497f901a03604c85b4fe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
FLT3-ITD POSITIVITY IN AML; CASE SERIES
por: Kemal FİDAN
Publicado: (2021) -
Falsely positive heparin‐induced thrombocytopenia antibody testing in severe hyperbilirubinemia
por: Daniel Egert, et al.
Publicado: (2021) -
PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
por: Seda Şahin, et al.
Publicado: (2021) -
Positive/external control of rapid diagnostic tests: A step forward in malaria screening
por: Rasika D Setia, et al.
Publicado: (2021) -
CHARACTERISTICS AND OUTCOME OF T(8;21)-POSITIVE CHILDHOOD ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION'S EXPERIENCE
por: Volkan KÖSE, et al.
Publicado: (2021)